SEC Comment Letter 0000000000-25-002050 to HeartSciences Inc. (HSCS, HSCSW) (CIK 0001468492) (HSCS)
HeartSciences Inc. (HSCS, HSCSW) (CIK 0001468492)
Date: Feb. 21, 2025 · CIK: 0001468492 · Accession: 0000000000-25-002050
AI Filing Summary & Sentiment
File numbers found in text: 024-12572
Letter
February 21, 2025 Andrew Simpson President, Chief Executive Officer and Chairman HeartSciences Inc. 550 Reserve St, Suite 360 Southlake, Texas 76092 Re:HeartSciences Inc. Offering Statement on Form 1-A Filed February 12, 2025 File No. 024-12572 Dear Andrew Simpson: This is to advise you that we do not intend to review your offering statement. We will consider qualifying your offering statement at your request. If a participant in your offering is required to clear its compensation arrangements with FINRA, please have FINRA advise us that it has no objections to the compensation arrangements prior to qualification. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257 of Regulation A requires you to file periodic and current reports, including a Form 1-K which will be due within 120 calendar days after the end of the fiscal year covered by the report. Please contact Margaret Sawicki at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Jonathan Shechter, Esq.
Show Raw Text
February 21, 2025
Andrew Simpson
President, Chief Executive Officer and Chairman
HeartSciences Inc.
550 Reserve St, Suite 360
Southlake, Texas 76092
Re:HeartSciences Inc.
Offering Statement on Form 1-A
Filed February 12, 2025
File No. 024-12572
Dear Andrew Simpson:
This is to advise you that we do not intend to review your offering statement.
We will consider qualifying your offering statement at your request. If a participant in
your offering is required to clear its compensation arrangements with FINRA, please have
FINRA advise us that it has no objections to the compensation arrangements prior to
qualification.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence
of action by the staff. We also remind you that, following qualification of your Form 1-A,
Rule 257 of Regulation A requires you to file periodic and current reports, including a Form
1-K which will be due within 120 calendar days after the end of the fiscal year covered by the
report.
Please contact Margaret Sawicki at 202-551-7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Jonathan Shechter, Esq.